Trial: 201905195

A Phase 1/2 First-in-human Study of BMS-986288 Alone and in Combination with Nivolumab in Advanced Malignant Tumors

Phase

I/II

Principal Investigator

Morgensztern, Daniel

Disease Site

Breast; Cervix; Colon; Esophagus; Kidney; Larynx; Lip, Oral Cavity and Pharynx; Lung; Melanoma, Skin; Other Digestive Organ; Rectum; Stomach; Urinary Bladder

Learn more about this study at: clinicaltrials.gov